Processa Pharmaceuticals (PCSA) Stock Chart & Stock Price History $1.15 -0.01 (-0.86%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Processa Pharmaceuticals Stock Price Performance5 Day Performance-14.81%1 Month Performance-13.53%3 Month Performance-40.10%6 Month Performance-49.12%Year-To-Date Performance-82.82%1 Year Performance-83.14% Receive PCSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here PCSA Stock Chart for Saturday, November, 2, 2024 PCSA Chart by TradingView Processa Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$1.16$1.15-0.43%$1.17$1.0618,272 shs$3.75 million10/31/2024$1.31$1.16-11.83%$1.35$1.1581,236 shs$3.76 million10/30/2024$1.35$1.31-2.96%$1.36$1.3110,715 shs$4.27 million10/29/2024$1.35$1.35$1.38$1.336,697 shs$4.40 million10/28/2024$1.31$1.35+3.05%$1.40$1.3341,135 shs$4.40 million10/25/2024$1.30$1.31+0.77%$1.35$1.2926,366 shs$3.74 million Get the Latest News and Ratings for PCSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$1.32$1.30-1.52%$1.35$1.2917,543 shs$3.72 million10/23/2024$1.34$1.32-1.49%$1.37$1.2926,903 shs$3.77 million10/22/2024$1.41$1.34-4.96%$1.42$1.3428,237 shs$3.83 million10/21/2024$1.40$1.41+0.71%$1.42$1.3639,767 shs$4.03 million10/18/2024$1.32$1.36+3.03%$1.40$1.3234,038 shs$3.89 million10/17/2024$1.32$1.32$1.37$1.2937,723 shs$3.77 million10/16/2024$1.24$1.32+6.45%$1.34$1.2259,115 shs$3.77 million10/15/2024$1.24$1.24$1.26$1.2131,285 shs$3.54 million10/14/2024$1.31$1.24-5.34%$1.31$1.2417,644 shs$3.54 million10/11/2024$1.26$1.29+2.38%$1.31$1.2214,513 shs$4.21 million10/10/2024$1.27$1.26-0.79%$1.29$1.2325,440 shs$3.60 million10/09/2024$1.26$1.27+0.79%$1.27$1.2031,727 shs$3.63 million10/08/2024$1.24$1.26+1.61%$1.29$1.2122,858 shs$3.60 million10/07/2024$1.19$1.24+4.20%$1.25$1.2044,842 shs$3.54 million10/04/2024$1.31$1.19-9.16%$1.30$1.19109,942 shs$3.40 million10/03/2024$1.33$1.31-1.50%$1.36$1.24326,956 shs$3.74 million10/02/2024$1.34$1.33-0.75%$1.33$1.302.03 million shs$3.80 million10/01/2024$1.37$1.34-2.19%$1.38$1.3113,452 shs$3.83 million09/30/2024$1.37$1.37$1.40$1.336,845 shs$3.92 million09/27/2024$1.29$1.37+6.18%$1.40$1.3019,349 shs$4.47 million09/26/2024$1.33$1.29-2.98%$1.37$1.2821,330 shs$4.21 million09/25/2024$1.34$1.33-0.60%$1.35$1.3014,804 shs$4.34 million09/24/2024$1.36$1.34-1.60%$1.37$1.3230,492 shs$3.82 million09/23/2024$1.36$1.36-0.02%$1.40$1.3513,298 shs$3.89 million09/20/2024$1.37$1.36-0.73%$1.38$1.3518,583 shs$3.89 million09/19/2024$1.42$1.37-3.52%$1.44$1.3516,450 shs$3.92 million09/18/2024$1.44$1.42-1.39%$1.45$1.364,273 shs$4.06 million09/17/2024$1.42$1.44+1.41%$1.47$1.3918,801 shs$4.12 million09/16/2024$1.34$1.42+5.97%$1.46$1.3425,483 shs$4.06 million09/13/2024$1.34$1.38+2.99%$1.40$1.3120,794 shs$4.50 million09/12/2024$1.34$1.34$1.34$1.315,534 shs$3.83 million09/11/2024$1.31$1.34+2.29%$1.34$1.317,914 shs$3.83 million09/10/2024$1.33$1.31-1.50%$1.33$1.299,417 shs$3.74 million09/09/2024$1.28$1.33+3.91%$1.34$1.2918,242 shs$3.80 millionCrypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now.09/06/2024$1.32$1.28-3.01%$1.36$1.2824,759 shs$3.66 million09/05/2024$1.39$1.32-5.06%$1.38$1.3042,013 shs$3.77 million09/04/2024$1.41$1.39-1.42%$1.39$1.3517,220 shs$4.53 million09/03/2024$1.38$1.41+2.17%$1.42$1.3521,388 shs$4.60 million09/02/2024$1.38$1.38$1.38$1.3411,600 shs$4.50 million08/30/2024$1.39$1.38-0.72%$1.39$1.3410,721 shs$3.94 million08/29/2024$1.43$1.39-2.80%$1.42$1.3537,049 shs$3.97 million08/28/2024$1.45$1.43-1.38%$1.45$1.4021,965 shs$4.09 million08/27/2024$1.45$1.45$1.48$1.4519,491 shs$4.14 million08/26/2024$1.45$1.45$1.52$1.4210,442 shs$4.14 million08/23/2024$1.50$1.45-3.33%$1.52$1.4330,576 shs$4.14 million08/22/2024$1.53$1.50-1.96%$1.57$1.4914,746 shs$4.29 million08/21/2024$1.51$1.53+1.32%$1.58$1.4668,100 shs$4.37 million08/20/2024$1.52$1.51-0.66%$1.51$1.4237,592 shs$4.32 million08/19/2024$1.45$1.52+4.83%$1.58$1.41229,914 shs$4.34 million08/16/2024$1.31$1.45+10.69%$1.49$1.3084,485 shs$4.14 million08/15/2024$1.35$1.31-2.96%$1.36$1.3055,469 shs$3.74 million08/14/2024$1.36$1.35-0.74%$1.40$1.3177,945 shs$3.86 million08/13/2024$1.46$1.36-6.85%$1.46$1.31106,870 shs$3.89 million08/12/2024$1.59$1.46-8.18%$1.56$1.43137,172 shs$4.17 million08/09/2024$1.67$1.59-4.79%$1.67$1.5946,172 shs$4.54 million08/08/2024$1.79$1.67-6.70%$1.80$1.58156,117 shs$4.77 million08/07/2024$1.86$1.79-3.76%$1.90$1.7550,775 shs$5.12 million08/06/2024$1.78$1.86+4.49%$1.90$1.7578,258 shs$5.32 million08/05/2024$1.92$1.78-7.29%$1.85$1.58196,650 shs$5.09 million08/02/2024$2.09$1.92-8.13%$2.12$1.77420,995 shs$5.49 million08/01/2024$2.10$2.09-0.48%$2.27$2.03721,559 shs$5.98 million Related Companies Oncternal Therapeutics Stock Price Chart Sol-Gel Technologies Stock Price Chart Synlogic Stock Price Chart GeoVax Labs Stock Price Chart HCW Biologics Stock Price Chart ImmunoPrecise Antibodies Stock Price Chart Talphera Stock Price Chart Marinus Pharmaceuticals Stock Price Chart Chemomab Therapeutics Stock Price Chart AIM ImmunoTech Stock Price Chart Receive PCSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCSA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.